Jasper Therapeutics, Inc.
JSPR
$0.72
$0.012.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 17.96M | 19.77M | 20.28M | 21.30M | 22.47M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 52.86M | 70.73M | 81.58M | 91.52M | 94.05M |
| Operating Income | -52.86M | -70.73M | -81.58M | -91.52M | -94.05M |
| Income Before Tax | -31.77M | -55.73M | -75.80M | -91.02M | -90.92M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -31.77 | -55.73 | -75.80 | -91.02 | -90.92 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -31.77M | -55.73M | -75.80M | -91.02M | -90.92M |
| EBIT | -52.86M | -70.73M | -81.58M | -91.52M | -94.05M |
| EBITDA | -52.30M | -69.94M | -80.53M | -90.51M | -92.73M |
| EPS Basic | -1.58 | -3.23 | -4.60 | -5.90 | -6.02 |
| Normalized Basic EPS | -0.91 | -1.94 | -2.80 | -3.62 | -3.76 |
| EPS Diluted | -1.58 | -3.23 | -4.60 | -5.90 | -6.02 |
| Normalized Diluted EPS | -0.91 | -1.94 | -2.80 | -3.62 | -3.76 |
| Average Basic Shares Outstanding | 102.67M | 89.31M | 75.66M | 62.00M | 60.37M |
| Average Diluted Shares Outstanding | 102.67M | 89.31M | 75.66M | 62.00M | 60.37M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |